(Q57954229)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

1 reference

1 reference

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

14

R E Chaisson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

N A Halsey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J S Coberly

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Desormeaux

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

P Losikoff

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Atkinson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Contave

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Johnson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

H Davis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

L Geiter

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

E Johnson

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R Huebner

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R Boulos

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

786-792

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

9105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

A prospective study of the risk of tuberculosis among HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

Isoniazid-associated hepatitis deaths: a review of available information

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 month

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

Tuberculin Skin Test Reactivity among Adults Infected with Human Immunodeficiency Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

Nationwide survey of drug-resistant tuberculosis in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

Surveillance of drug resistance for tuberculosis control: why and how?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

Control strategies for tuberculosis epidemics: new models for old problems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906532-X

7 January 2021

10.1016/S0140-6736(97)06532-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9519950%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference